Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
67.33 USD | -0.44% | -0.50% | +8.20% |
May. 16 | Axonics Implant Approved in Australia to Treat Overactive Bladders | MT |
May. 16 | Axonics, Inc. Receives Regulatory Approval for Recharge-Free SNM System in Australia | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.20% | 3.45B | |
+10.24% | 128B | |
-8.89% | 11.26B | |
+3.31% | 9.28B | |
+35.16% | 5.42B | |
-23.90% | 4.8B | |
-10.69% | 2.8B | |
-12.15% | 2.1B | |
-11.96% | 1.98B | |
-27.62% | 1.71B |
- Stock Market
- Equities
- AXNX Stock
- News Axonics, Inc.
- Axonics to File for Review After Patent Board Invalidates Claims in Medtronic Case